Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Malignant Lymphoma

Free Subscription 01.12.2025 2 Blood 3 BMC Cancer 1 Bone Marrow Transplant 1 Br J Cancer 1 Cancer 3 Haematologica 1 J Am Acad Dermatol 1 Oncogene 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Blood

1. 
   Yeung DT, Shanmuganathan N, Reynolds J, et al; Australasian Leukaemia and Lymphoma Group. Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study. Blood. 2024;144(19):1993-2001.
   Blood. 2025;146:2729.
   PubMed        
   
   
2. HOSOYA H, Bastidas Torres AN, Fernandez-Pol S, Gubatan JM, et al
   Long-term Follow-up of Gastrointestinal CAR T-cell Lymphoma: Homing, Clonal Expansion, and Response to Cyclosporine.
   Blood. 2025 Nov 25:blood.2025031423. doi: 10.1182/blood.2025031423.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. ZENG C, Wei Z, Huang J, Zhu J, et al
   Prognostic implication of serum levels of IL-6 and IL-10 in children and adolescents with aggressive mature B-cell non-Hodgkin lymphoma.
   BMC Cancer. 2025 Nov 26. doi: 10.1186/s12885-025-15377.
   PubMed         Abstract available
   
   
4. DAWOOD S, McMillan B, Brown K, Oosthuizen J, et al
   Early-stage Hodgkin lymphoma in Cape Town, South Africa: prognostic risk factors at diagnosis and treatment outcomes.
   BMC Cancer. 2025;25:1813.
   PubMed         Abstract available
   
   
5. XIN W, Wang F, Lu L, Zang H, et al
   Tumor metabolic heterogeneity based on (18)F-FDG PET/CT is a predictor of outcome in diffuse large B-cell lymphoma.
   BMC Cancer. 2025;25:1807.
   PubMed         Abstract available
   
   

   
   Bone Marrow Transplant

6. LOPEZ-PEREIRA P, Romero Dominguez S, Martin-Moro F, Caballero AC, et al
   Outcomes of de novo primary central nervous system lymphoma using the MATRix regimen for induction followed by thiotepa-based conditioning: a GELTAMO analysis.
   Bone Marrow Transplant. 2025 Nov 27. doi: 10.1038/s41409-025-02772.
   PubMed        
   
   

   
   Br J Cancer

7. HERMOSA S, Benavente Y, Cabezudo E, Sainz J, et al
   Serum lipid levels and risk of lymphoid malignancies in the UK Biobank study.
   Br J Cancer. 2025;133:1686-1694.
   PubMed         Abstract available
   
   

   
   Cancer

8. SHI W, Ren Y, Liu S, Liu Y, et al
   Clinical characteristics and survival outcomes of thymic mucosa-associated lymphoid tissue lymphoma: A multicenter analysis of 82 patients.
   Cancer. 2025;131:e70183.
   PubMed         Abstract available
   
   

   
   Haematologica

9. OLSZEWSKI AJ, Ollila TA, Chihara D, Shouse G, et al
   Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphoma.
   Haematologica. 2025 Nov 27. doi: 10.3324/haematol.2025.288946.
   PubMed         Abstract available
   
   
10. KIENER TA, Schweighofer-Zwink G, Rendl G, Kern JM, et al
    Complete remission of bronchus-associated lymphoid tissue lymphoma after antibiotic treatment for Tropheryma whipplei.
    Haematologica. 2025 Nov 27. doi: 10.3324/haematol.2025.288045.
    PubMed         Abstract available
    
    
11. JOFFE E, Uppal M, Zheng S, Bantilan KS, et al
    Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphoma.
    Haematologica. 2025 Nov 27. doi: 10.3324/haematol.2024.286813.
    PubMed         Abstract available
    
    

    
    J Am Acad Dermatol

12. MOODY W, Marti AA, Alsawas M, Mou E, et al
    Cutaneous T-cell Lymphoma in Pregnancy and Post-Partum Period: A Systematic Review.
    J Am Acad Dermatol. 2025 Nov 24:S0190-9622(25)03272.
    PubMed        
    
    

    
    Oncogene

13. GUO W, Wang X, Cui G, Schmieder EAS, et al
    Aberrant lipid metabolism renders an aggressive behavior of T-lymphoblastic lymphoma in a MASH model.
    Oncogene. 2025 Nov 26. doi: 10.1038/s41388-025-03630.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

14. GUI A, Yan Y, Jiang S, Chen F, et al
    USP1-TRAF2 axis-regulated mortalin stability mediates chemoresistance by disrupting calcium transport in peripheral T-cell lymphoma.
    Proc Natl Acad Sci U S A. 2025;122:e2504195122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.